All systems operational
Q1 2022

Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia

Waleed H. Mahallawi · Mohammad A. Alsarani · Rami H. Aljohani · Abdulrahman A. Alluhaibi · Turki H. Alamri · Nadir A. Ibrahim · Khalid H. Mahallawi · Omar F. Khabourd
10.5144/0256-4947.2022.69 386 Views 0 Citations
0
Citations
386
Views
Abstract


BACKGROUND:
The coronavirus disease 2019 (COVID-19) pandemic has had a massive impact on public health as well as the economy. Understanding the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among undiagnosed individuals is important for developing an informed pandemic response.


OBJECTIVE:
Investigate the prevalence of undiagnosed COVID-19 disease.


DESIGN:
Cross-sectional.


SETTING:
Tertiary care center in Madinah, Saudi Arabia.


SUBJECTS AND METHODS:
All participants were on follow-up visits to various clinics and had not been previously diagnosed with COVID-19. Enzyme-linked immunosorbent assay was used to specifically assess the anti-spike IgG antibody seropositivity in serum samples. We associated the seropositivity rates of the participants with age, body mass index (BMI), nationality, blood groups, and sex with uni- and multivariate analyses.


MAIN OUTCOME MEASURES:
Seropositivity for IgG anti-spike antibodies against SARS-CoV-2.


SAMPLE SIZE AND CHARACTERISTICS:
527 subjects, with a median (interquartile percentiles) age of the 527 subjects was 34 (24–41).


RESULTS:

Of the 527 samples, about one-fourth (n=124, 23.5%) were positive for anti-spike IgG antibody against SARS CoV-2. Age was associated with anti-spike IgG antibody positivity (
P
<.002). Participants >30 years were more likely to be seropositive (28-29%) than younger participants (15.4%). Additionally, seropositivity was associated with female gender (
P
<.001) and a higher BMI (
P
<.006). In the multivariate logistic regression, age >30, female gender and BMI >40 were associated with seropositivity.



CONCLUSION:
The percentage of seropositive individuals reflects the high level of undiagnosed COVID-19 patients among the population. Our results will help in a better evaluation of the public health measures applied during the COVID-19 pandemic and any future public health crises.


LIMITATIONS:
Sample size was small, single-center study and no rural areas were included.


CONFLICT OF INTEREST:
None.

Cite this Article (APA)
Waleed, H. M., Mohammad, A. A., Rami, H. A., Abdulrahman, A. A., Turki, H. A., Nadir, A. I., Khalid, H. M., Omar, F. K. (2022). Seroprevalence of SARS-Cov-2 IgG antibodies in patients at a single center in Saudi Arabia. Annals of Saudi Medicine. https://doi.org/10.5144/0256-4947.2022.69
Related Papers
Evaluation of the systemic immune inflammation index and the systemic inflammatory response index as…
Fatma Özcan Siki; Mehmet Sarıkaya; Metin Gunduz; Tamer Sekmenli; Muslu Kazim Kor · 2023
22
cites
394
Intracoronary epinephrine versus adenosine in the management of refractory no-reflow phenomenon: a s…
Ahmed Darwish; Abdel-Fattah Frere; Magdy Abdelsamie; Waleed El Awady; Mohammad G · 2022
17
cites
389
Association between serum vitamin D levels and age in patients with epilepsy: a retrospective study …
Hussam Mohammed Alhaidari; Fawzi Babtain; Khalid Alqadi; Abdulrahman Bouges; Sal · 2022
16
cites
393
15
cites
395
Access
View Full Text via DOI
Published in
ISSN 0256-4947
Quartile Q1
AMS Score 90
Field Medicine & Health Sciences
Publisher King Faisal Specialist Hospital and
Country 🇸🇦 Saudi Arabia
View Journal Profile →
Authors
Publication Details
Year 2022
Language English
Added 30 Jul 2026